Metastases of esophageal carcinoma to skeletal muscle: single center experience

. 2012 Sep 21 ; 18 (35) : 4962-6.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu kazuistiky, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid23002370

Metastases of esophageal carcinoma to the skeletal muscle are rare, but the incidence may be increasing because of better diagnosis resulting from widespread use of positron emission tomography/computed tomography (PET/CT). A cohort of 205 patients with esophageal carcinoma treated at our center who had PET/CT between 2006 and 2010 was retrospectively evaluated for the presence of skeletal muscle metastases. Four patients had skeletal muscle metastases of esophageal carcinoma, including two patients with squamous cell carcinoma. In another patient with squamous cell carcinoma of the esophagus and synchronous skeletal muscle metastases, muscle metastases were subsequently shown to be related to second primary pancreatic adenocarcinoma. In all cases, skeletal muscle metastases were the first manifestation of systemic disease. In three patients palliation was obtained with the combination of external beam radiation therapy, systemic chemotherapy or surgical resection. Skeletal muscle metastases are a rare complication of esophageal carcinoma.

Zobrazit více v PubMed

Kollarova H, Machova L, Horakova D, Janoutova G, Janout V. Epidemiology of esophageal cancer--an overview article. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007;151:17–20. PubMed

Mandard AM, Chasle J, Marnay J, Villedieu B, Bianco C, Roussel A, Elie H, Vernhes JC. Autopsy findings in 111 cases of esophageal cancer. Cancer. 1981;48:329–335. PubMed

Quint LE, Hepburn LM, Francis IR, Whyte RI, Orringer MB. Incidence and distribution of distant metastases from newly diagnosed esophageal carcinoma. Cancer. 1995;76:1120–1125. PubMed

Herring CL, Harrelson JM, Scully SP. Metastatic carcinoma to skeletal muscle. A report of 15 patients. Clin Orthop Relat Res. 1998;(355):272–281. PubMed

Schultz SR, Bree RL, Schwab RE, Raiss G. CT detection of skeletal muscle metastases. J Comput Assist Tomogr. 1986;10:81–83. PubMed

Tuoheti Y, Okada K, Osanai T, Nishida J, Ehara S, Hashimoto M, Itoi E. Skeletal muscle metastases of carcinoma: a clinicopathological study of 12 cases. Jpn J Clin Oncol. 2004;34:210–214. PubMed

Damron TA, Heiner J. Distant soft tissue metastases: a series of 30 new patients and 91 cases from the literature. Ann Surg Oncol. 2000;7:526–534. PubMed

Lee BY, Choi JE, Park JM, Jee WH, Kim JY, Lee KH, Kim HS, Song KS. Various image findings of skeletal muscle metastases with clinical correlation. Skeletal Radiol. 2008;37:923–928. PubMed

Bosch A, Frias Z, Caldwell WL, Jaeschke WH. Autopsy findings in carcinoma of the esophagus. Acta Radiol Oncol Radiat Phys Biol. 1979;18:103–112. PubMed

Chan KW, Chan EY, Chan CW. Carcinoma of the esophagus. An autopsy study of 231 cases. Pathology. 1986;18:400–405. PubMed

Surov A, Hainz M, Holzhausen HJ, Arnold D, Katzer M, Schmidt J, Spielmann RP, Behrmann C. Skeletal muscle metastases: primary tumours, prevalence, and radiological features. Eur Radiol. 2010;20:649–658. PubMed

Weiss L. Biomechanical destruction of cancer cells in skeletal muscle: a rate-regulator for hematogenous metastasis. Clin Exp Metastasis. 1989;7:483–491. PubMed

Seely S. Possible reasons for the high resistance of muscle to cancer. Med Hypotheses. 1980;6:133–137. PubMed

van Westreenen HL, Westerterp M, Bossuyt PM, Pruim J, Sloof GW, van Lanschot JJ, Groen H, Plukker JT. Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer. J Clin Oncol. 2004;22:3805–3812. PubMed

Kato H, Miyazaki T, Nakajima M, Takita J, Kimura H, Faried A, Sohda M, Fukai Y, Masuda N, Fukuchi M, et al. The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer. 2005;103:148–156. PubMed

Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, et al. Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma. J Clin Oncol. 2000;18:3202–3210. PubMed

Luketich JD, Martini N, Ginsberg RJ, Rigberg D, Burt ME. Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg. 1995;60:1609–1611. PubMed

Heyer CM, Rduch GJ, Zgoura P, Stachetzki U, Voigt E, Nicolas V. Metastasis to skeletal muscle from esophageal adenocarcinoma. Scand J Gastroenterol. 2005;40:1000–1004. PubMed

Rehman SU, Cope DW, Basile JN. Metastatic gastroesophageal adenocarcinoma to skeletal muscle: a unique event. South Med J. 2002;95:1076–1078. PubMed

Kozyreva ON, Mezentsev DA, King DR, Gomez-Fernandez CR, Ardalan B, Livingstone AS. Asymptomatic muscle metastases from esophageal adenocarcinoma. J Clin Oncol. 2007;25:3780–3783. PubMed

Heffernan E, Fennelly D, Collins CD. Multiple metastases to skeletal muscle from carcinoma of the esophagus detected by FDG PET-CT imaging. Clin Nucl Med. 2006;31:810–811. PubMed

Wu G, Bybel B, Brunken R, Lin H, Neumann D. PET detection of solitary distant skeletal muscle metastasis of esophageal adenocarcinoma. Clin Nucl Med. 2005;30:335–337. PubMed

Lekse JM, Zhang J, Mawn LA. Metastatic gastroesophageal junction adenocarcinoma to the extraocular muscles. Ophthalmology. 2003;110:318–321. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...